ATE522203T1 - Pharmazeutische herstellung zur bindung von acetaldehyd in speichel, magen und dickdarm - Google Patents

Pharmazeutische herstellung zur bindung von acetaldehyd in speichel, magen und dickdarm

Info

Publication number
ATE522203T1
ATE522203T1 AT01980581T AT01980581T ATE522203T1 AT E522203 T1 ATE522203 T1 AT E522203T1 AT 01980581 T AT01980581 T AT 01980581T AT 01980581 T AT01980581 T AT 01980581T AT E522203 T1 ATE522203 T1 AT E522203T1
Authority
AT
Austria
Prior art keywords
saliva
stomach
large intestine
pharmaceutical production
binding acetaldehyde
Prior art date
Application number
AT01980581T
Other languages
English (en)
Inventor
Mikko Salaspuro
Martti Marvola
Original Assignee
Biohit Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oyj filed Critical Biohit Oyj
Application granted granted Critical
Publication of ATE522203T1 publication Critical patent/ATE522203T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01980581T 2000-10-30 2001-10-30 Pharmazeutische herstellung zur bindung von acetaldehyd in speichel, magen und dickdarm ATE522203T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20002392A FI121528B (fi) 2000-10-30 2000-10-30 Farmaseuttinen koostumus syöpään sairastumisen riskin vähentämiseen paikallisesti sitomalla asetaldehydi syljessä, mahalaukussa tai paksusuolessa
PCT/FI2001/000948 WO2002036098A1 (en) 2000-10-30 2001-10-30 Method and preparation for binding acetaldehyde in saliva, stomach and large intestine

Publications (1)

Publication Number Publication Date
ATE522203T1 true ATE522203T1 (de) 2011-09-15

Family

ID=8559405

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01980581T ATE522203T1 (de) 2000-10-30 2001-10-30 Pharmazeutische herstellung zur bindung von acetaldehyd in speichel, magen und dickdarm

Country Status (10)

Country Link
US (1) US9474733B2 (de)
EP (1) EP1339394B1 (de)
JP (1) JP4691312B2 (de)
CN (1) CN100467016C (de)
AT (1) ATE522203T1 (de)
AU (1) AU2002212395A1 (de)
EA (1) EA009335B1 (de)
ES (1) ES2370811T3 (de)
FI (1) FI121528B (de)
WO (1) WO2002036098A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI121528B (fi) 2000-10-30 2010-12-31 Biohit Oyj Farmaseuttinen koostumus syöpään sairastumisen riskin vähentämiseen paikallisesti sitomalla asetaldehydi syljessä, mahalaukussa tai paksusuolessa
EP1609468A3 (de) 2000-11-22 2006-01-25 Rxkinetix, Inc. Eine Zusammensetzung auf der Basis eines Schwefel enthaltenden Antioxidans wie dessen Verwendung zur Herstellung eines Medikaments für die Behandlung von Mucositis
JP5654726B2 (ja) * 2004-10-08 2015-01-14 ビオヒット・ユルキネン・オサケユキテュアＢｉｏｈｉｔ Ｏｙｊ 唾液中のアルデヒド類を結合するための方法および製剤
ITME20040015A1 (it) * 2004-12-07 2005-03-07 Vincenzo Savica Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
FI122914B (fi) 2005-04-01 2012-08-31 Biohit Oyj Elintarvikekoostumus asetaldehydin sitomiseksi suussa ja ruoansulatuskanavassa ja menetelmä koostumuksen valmistamiseksi
CA2615319A1 (en) * 2005-07-13 2007-01-18 Al Czap Compositions for oral administration of sustained release glutathione, methods for their production and uses thereof
CA2635603C (en) 2005-11-30 2016-01-19 Endo Pharmaceuticals Inc. Treatment of xerostomia
FI20060501A7 (fi) * 2006-05-22 2007-11-23 Biohit Oyj Koostumus ja menetelmä asetaldehydin sitomiseksi mahalaukussa
US20100166833A1 (en) * 2007-05-07 2010-07-01 Technion Research & Development Foundation Ltd. Compositions, articles and methods for preventing or reducing tobacco-associated damage
FI120526B (fi) * 2007-05-16 2009-11-30 Biohit Oyj Filtteri tupakkatuotteeseen
FI20070705L (fi) * 2007-09-14 2009-06-02 Biohit Oyj Asetaldehydin sitominen suussa ja mahalaukussa
WO2009048780A1 (en) * 2007-10-08 2009-04-16 The University Of Kentucky Research Foundation Polymer-metal chelator conjugates and uses thereof
IL188681A0 (en) * 2008-01-09 2008-12-29 Amino Acid Solutions Inc Pharmaceutical compositions and methods utilizing a d-amino acid
FI20115680L (fi) * 2011-06-29 2012-12-30 Biohit Oyj Nestemäisiä farmaseuttisia koostumuksia tai yhdistelmätuotteita
FI129157B (en) * 2012-05-28 2021-08-13 Biohit Oyj Composition for use in reducing the incidence of or preventing severe headaches
FI20135097A7 (fi) * 2013-02-01 2014-08-02 Biohit Oyj Koostumus aldehydien sitomiseen suussa
KR20150126382A (ko) 2013-03-12 2015-11-11 바이오히트 오와이제이 위 내의 알데하이드에 결합하는 캡슐화된 조성물
CA2905236A1 (en) 2013-03-12 2014-09-18 Biohit Oyj Composition for oral administration for binding aldehydes in the gastrointestinal tract
FI20145217A7 (fi) 2014-03-06 2015-09-07 Biohit Oyj Koostumus aldehydien ja vapaiden radikaalien sitomiseksi ruoansulatuskanavassa
CN108671232A (zh) * 2018-07-09 2018-10-19 珠海中科先进技术研究院有限公司 一种能够降低体内乙醛浓度的组合制剂及其制备方法与用途
JP7549593B2 (ja) 2019-03-15 2024-09-11 ノヴォ ノルディスク アー／エス Ｇｌｐ－１ペプチドを噴霧乾燥するためのプロセス
US11717554B2 (en) * 2019-09-19 2023-08-08 Max R&D Llc Method for preventing or treating hangover symptom(s) associated with consumption of alcoholic beverage(s)
CN119214993A (zh) * 2024-09-27 2024-12-31 国家纳米科学中心 用于清除醛基的透明质酸纳米凝胶、其制备方法和应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4472428A (en) * 1980-12-09 1984-09-18 Teijin Limited Halogenated prostacyclins pharmaceutical use thereof and hydroxy intermediates therefore
US4496548A (en) 1983-02-04 1985-01-29 Moldowan Mervin J Composition and method for reducing hangover
GB8313044D0 (en) 1983-05-12 1983-06-15 Caseley J R Reducing toxic effects of tobacco
US4528295A (en) * 1983-08-15 1985-07-09 Boris Tabakoff Composition and method for reducing blood acetaldehyde levels
JPS6116144A (ja) 1984-06-29 1986-01-24 Fujitsu Ten Ltd 異常シフト警報装置
PH22818A (en) * 1986-02-18 1989-01-19 Takeda Chemical Industries Ltd Composition and method for reducing acetaldehyde toxicity
US5202354A (en) * 1986-02-18 1993-04-13 Takeda Chemical Industries, Ltd. Composition and method for reducing acetaldehyde toxicity
JPS62195323A (ja) * 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
CH674148A5 (de) * 1986-06-24 1990-05-15 Racz Istvan
DE3775880D1 (de) * 1986-09-18 1992-02-20 London School Of Pharmacy Innovations Ltd., London, Gb
HU201865B (en) 1989-04-28 1991-01-28 Pecsi Dohanygyar Tobacco-smoke filter of high efficiency
JPH0374327A (ja) 1989-08-16 1991-03-28 Ajinomoto Co Inc アルコール代謝促進剤
JPH03136895A (ja) 1989-10-23 1991-06-11 Fuji Electric Co Ltd 光情報記録媒体の製造方法
JPH0421635A (ja) 1990-05-16 1992-01-24 Suntory Ltd アセトアルデヒドの毒性抑制剤およびアセトアルデヒドの毒性抑制に有効な飲食物
US5110423A (en) * 1990-05-25 1992-05-05 Technic Inc. Bath for electroplating bright tin or tin-lead alloys and method thereof
JP3013860B2 (ja) 1991-03-22 2000-02-28 三菱瓦斯化学株式会社 食品保存剤およびこれを用いた食品の保存方法
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
JP3479986B2 (ja) 1992-10-07 2003-12-15 大正製薬株式会社 アルコール性肝障害予防用組成物
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
JPH09194361A (ja) * 1996-01-19 1997-07-29 Wakunaga Pharmaceut Co Ltd 抗腫瘍剤
WO1998003260A1 (en) 1996-07-22 1998-01-29 Kouki Bussan Yugenkaisha Novel adsorbent
IN186245B (de) * 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US5829449A (en) 1997-09-19 1998-11-03 Thione International, Inc. Smoking products containing antioxidants
US5922346A (en) 1997-12-01 1999-07-13 Thione International, Inc. Antioxidant preparation
WO2000071145A1 (en) 1999-05-24 2000-11-30 Hee Jung Kim Composition for recovering from a hangover and for preventing brain cell damage
US6635273B1 (en) * 1999-10-29 2003-10-21 Trustees Of Boston University Methods of treating vascular diseases characterized by nitric oxide insufficiency
FI121528B (fi) 2000-10-30 2010-12-31 Biohit Oyj Farmaseuttinen koostumus syöpään sairastumisen riskin vähentämiseen paikallisesti sitomalla asetaldehydi syljessä, mahalaukussa tai paksusuolessa
ITPI20010014A1 (it) 2001-03-05 2002-09-05 Ivo Pera Composto per filtri per sigarette,o altri articoli da fumo,a base di sostanze antiossidanti ed il filtro cosi'ottenuto
WO2002098405A1 (fr) 2001-06-05 2002-12-12 Ajinomoto Co., Inc. Inhibiteurs de fibrose du foie
JP2003055215A (ja) 2001-06-05 2003-02-26 Ajinomoto Co Inc 肝線維化抑制剤
US6936283B2 (en) 2003-07-25 2005-08-30 Langeland Bjoern T. Composition for stimulation of specific metallo-enzymes
DE602005025313D1 (de) 2004-02-17 2011-01-27 Matuschka Greiffenclau Markus Zusammensetzung zur veränderung des alkoholstoffwechsels

Also Published As

Publication number Publication date
JP4691312B2 (ja) 2011-06-01
JP2004512353A (ja) 2004-04-22
EP1339394A1 (de) 2003-09-03
WO2002036098A1 (en) 2002-05-10
US20050267042A1 (en) 2005-12-01
ES2370811T3 (es) 2011-12-23
FI121528B (fi) 2010-12-31
CN1486177A (zh) 2004-03-31
FI20002392A0 (fi) 2000-10-30
FI20002392L (fi) 2002-05-01
US9474733B2 (en) 2016-10-25
EP1339394B1 (de) 2011-08-31
AU2002212395A1 (en) 2002-05-15
EA009335B1 (ru) 2007-12-28
CN100467016C (zh) 2009-03-11
EA200300532A1 (ru) 2003-10-30

Similar Documents

Publication Publication Date Title
ATE522203T1 (de) Pharmazeutische herstellung zur bindung von acetaldehyd in speichel, magen und dickdarm
ATA1292000A (de) Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
ATE430555T1 (de) Pharmazeutische zusammensetzungen zur behandlung von asthma
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
DE50212243D1 (de) Prozess zur herstellung von aryl-aryl gekoppelten verbindungen
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
NO331093B1 (no) Somatostatinanaloger, fremgangsmåte for fremstilling, farmasøytisk sammensetning og anvendelse derav.
SE0102315D0 (sv) Compounds
EE200300145A (et) Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon
EE200200487A (et) Asetidiini derivaadid, nende valmistamismeetodid ja farmatseutiline kompositsioon
BR9808933A (pt) Composição sob forma de microcápsulas ou de implantes, processo de preparação de uma substância hidrossolúvel, substância ativa, acetato de triptorelina, acetato de lanreotìdeo, ou acetato de octreotìdeo, e rna de filamento duplo
TR200003788A3 (tr) Yavas salimli oral dozaj bilesim.
ATE478840T1 (de) 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung
EE04464B1 (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
DE69909135D1 (de) Orale zubereitung zur bekämpfung von mundgeruch
ITTO20000779A0 (it) Composizioni farmaceutiche.
EE05020B1 (et) Glburiidi ravimkoostis
DE60132600D1 (de) Medikamente zur chemotherapeutischen behandlung von erkrankungen
DE60108042D1 (de) Prozesse zur Herstellung von pulverförmigen Schlagzäh-Modifizierern
ATE330017T1 (de) Kallikrein gen
DE59813162D1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
ATE464878T1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
ATE286894T1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties